Suppr超能文献

血管化淋巴结转移治疗乳腺癌相关淋巴水肿的系统评价和荟萃分析。

A systematic review and meta-analysis of vascularized lymph node transfer for breast cancer-related lymphedema.

机构信息

Department of Plastic and Reconstructive Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Plastic and Reconstructive Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

J Vasc Surg Venous Lymphat Disord. 2022 May;10(3):786-795.e1. doi: 10.1016/j.jvsv.2021.08.023. Epub 2021 Sep 8.

Abstract

BACKGROUND

Vascularized lymph node transfer (VLNT) has become an increasingly popular technique for treating lymphedema. However, although many studies have been performed, its efficacy in increasing patients' quality of life (QoL) and reducing lymphedema in the affected body part has remained controversial. In the present systematic review, we summarized the evidence for VLNT for treating breast cancer-related lymphedema.

METHODS

The MEDLINE, Embase, and Cochrane Central databases were searched for studies of patients with breast cancer-related lymphedema who had received VLNT. The study methods were assessed using the MINORS (methodologic index for nonrandomized studies) tool. The primary outcomes were the change in volume difference between the arms and QoL. The secondary outcomes were skin infection, complications, and discontinuation of compression garment use.

RESULTS

A total of 17 studies were included for qualitative synthesis and 8 for meta-analysis. The average reduction rate between the healthy and affected arms in the studies included in the meta-analysis was 40.31%. Five studies had evaluated QoL, and all five studies had reported that QoL was significantly increased. Eight studies had evaluated skin infections, of which three had reported the annual infection rates before and after surgery. In these studies, infection rate had decreased significantly. Three studies had described usage of compression garments. When the patients were pooled, 27 of 60 were able to discontinue use of the compression garment. The donor and recipient complication rates were 12.1% and 7.3%, respectively.

CONCLUSIONS

The current evidence indicates that VLNT can improve the volume differences between the arms in patients with unilateral lymphedema by ∼40%. In addition, although determined from a few studies, it is likely that VLNT has a positive effect on patients' QoL, the number of skin infections, and compression garment usage and coincided with a low complication rate.

摘要

背景

带血管的淋巴结转移(VLNT)已成为治疗淋巴水肿的一种越来越受欢迎的技术。然而,尽管已经进行了许多研究,但它在提高患者生活质量(QoL)和减轻受影响身体部位的淋巴水肿方面的疗效仍存在争议。在本系统评价中,我们总结了 VLNT 治疗乳腺癌相关淋巴水肿的证据。

方法

检索了 MEDLINE、Embase 和 Cochrane 中央数据库中接受 VLNT 的乳腺癌相关淋巴水肿患者的研究。使用 MINORS(非随机研究方法学指数)工具评估研究方法。主要结局是手臂间体积差异的变化和 QoL。次要结局是皮肤感染、并发症和压缩衣使用的中断。

结果

共有 17 项研究进行了定性综合分析,8 项进行了荟萃分析。荟萃分析纳入的研究中,健康手臂和患病手臂之间的平均减少率为 40.31%。五项研究评估了 QoL,五项研究均报告 QoL 显著提高。八项研究评估了皮肤感染,其中三项研究报告了手术前后的年度感染率。在这些研究中,感染率显著下降。三项研究描述了压缩衣的使用情况。当汇总患者时,60 人中的 27 人能够停止使用压缩衣。供体和受者并发症发生率分别为 12.1%和 7.3%。

结论

目前的证据表明,VLNT 可以将单侧淋巴水肿患者手臂间的体积差异改善约 40%。此外,尽管仅来自少数研究,但 VLNT 很可能对患者的 QoL、皮肤感染数量和压缩衣使用有积极影响,且并发症发生率较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验